https://staging.moocwiki.org/index.php?action=history&feed=atom&title=Aging%2FResearch_reports%2F2026-10-06Aging/Research reports/2026-10-06 - Versionsgeschichte2026-10-10T10:27:58ZVersionsgeschichte dieser Seite in MOOCsWiki StagingMediaWiki 1.46.0https://staging.moocwiki.org/index.php?title=Aging/Research_reports/2026-10-06&diff=62273&oldid=prevGlanz: Aging daily 78d9d1c2f010426691db2e48b3fc6ae7 c8722ed73c672026-10-06T06:44:51Z<p>Aging daily 78d9d1c2f010426691db2e48b3fc6ae7 c8722ed73c67</p>
<p><b>Neue Seite</b></p><div>__NOTOC__<br />
<div class="aging-research-world aging-journal" lang="en"><br />
<div class="aj-masthead"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aging-languages" role="navigation" aria-label="Sprache / Language"><span class="aging-language" title="Deutsch">[[Altern/Forschungsberichte/2026-10-06|🇩🇪]]</span><span class="aging-language" title="English">[[Aging/Research reports/2026-10-06|🇬🇧]]</span></div></div><br />
<div class="aj-context"><strong>An evolving AI research project</strong>[[Aging/About the project|Background · goals · methods]]<span>Updated 6 Oct 2026</span></div><br />
<h1>What is the claimed memory benefit compared with?</h1><br />
<div class="aj-deck">Research report · 6 October 2026 · TIMP2 and direct functional comparisons</div><br />
<div class="aj-article"><br />
<br />
<div class="aj-kicker">Brain & proteins · Choosing the right comparison</div><br />
== Better than chance does not automatically mean better than control ==<br />
'''Today’s decision:''' The Y-maze analyses in AG-R08 do not by themselves establish a direct memory benefit of treatment over vehicle. We constrain this evidence route for AG-C03/AG-T01 without rejecting TIMP2 overall. '''🔵 Project Level 2, low confidence in the combined hypothesis'''. The original study remains '''⚪ Level 1, preclinical indications with endpoint-specific limits'''.<br />
<br />
== What was actually compared ==<br />
Britton et al., ''Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in Aging'', DOI '''10.1523/ENEURO.0031-23.2023''': publisher heading '''15 June 2023''', differing PMC heading '''12 June 2023'''; the date assignment remains unresolved. Retrieved and assessed '''6 October 2026'''. [https://www.eneuro.org/content/10/6/ENEURO.0031-23.2023 Original article] · [https://pmc.ncbi.nlm.nih.gov/articles/PMC10275401/ Original text at PMC].<br />
<br />
Figure 1D concerns 23-month-old male C57BL/6J mice, 8–13 per group. The reported Wilcoxon tests compare each group separately with 50 percent novel-arm entries: vehicle p=0.3301, TIMP2 p=0.0425, TIMP2-hIgG4 p=0.0469. These are authors’ statistics, not our calculations. Figure 6A also tests against chance.<br />
<br />
'''The decisive gap:''' “Significant in treatment, not significant in control” does not establish a significant difference between groups. Nor does it establish lack of efficacy or absence of memory in control mice. A direct difference with an uncertainty interval at mouse level is required. Such cognitive contrasts are not reported in the audited analyses.<br />
<br />
== Which positive findings remain ==<br />
For nesting, Figure 1C reports direct vehicle comparisons. That is a different behavioural endpoint and cannot replace a direct memory comparison. Synaptic density measures also receive direct comparisons; multiple images within a mouse are nested measurements. Without a complete aggregation audit, we assume neither independent images nor a demonstrated statistical error. More counted synaptic puncta alone do not establish functional connections maintained over time.<br />
<br />
Four weeks of treatment with behavioural testing in week 3 also do not provide four weeks of persistent benefit after treatment withdrawal. Balancing groups by baseline performance is described; verified random allocation and blinded cognitive assessment cannot be inferred from that. All authors declared employment at Alkahest or Grifols; this is a disclosed conflict of interest, not proof of incorrect results.<br />
<br />
== How this changes our hypothesis ==<br />
'''Our inference:''' AG-T01 requires two separate links: first a robust functional difference, then evidence that selective cargo degradation while preserving useful synapses mediates that difference. Chance-level tests alone do not establish the first link. Neuronal or matrix effects, motivation and baseline differences remain alternative explanations. The axolotl branch is unchanged without new case linkage; its distinction between signalling, pattern and function is not presented as a shared biological mechanism.<br />
<br />
'''Next executable step:''' First verify publication/version metadata, accessible original methods and cohort dependencies for a human proteomic-PRS paper found today, DOI 10.1016/j.neurobiolaging.2025.10.003. It is currently only a screening candidate. Genetically predicted TIMP2, measured plasma levels and administered TIMP2 are different exposures. Direct publisher access failed; an association will not be adopted in advance as a treatment effect. For AG-R08, reanalysis of available mouse-level data remains a separate potential check; no raw data were analysed today.<br />
<br />
== Evidence and search limits ==<br />
* '''Established within this audit:''' Different questions require different statistical contrasts; the cited legends document chance-level tests.<br />
* '''Promising indications:''' Nesting and synaptic findings justify further examination of TIMP2.<br />
* '''Experimental results:''' Mouse findings during treatment, not demonstrated human rejuvenation or lasting functional rescue.<br />
* '''Hypothesis:''' Functional benefit might arise through neuronal, matrix or microglial pathways; selective cargo mediation remains untested.<br />
<br />
We read indexed original methods and legends, not figure pixels or raw data. The targeted DOI search found no matching correction/retraction notice, without a completeness guarantee. Source delta '''0''': 27 registered studies and one new unappraised candidate. Existing professor assignments AG-P01/16/18 cover the contrast and uncertainty check; no duplicate wish. [[Aging/Search log|Search log]] · [[Aging/Evidence chain|Evidence chain]] · [[Aging/Approaches to aging|Approaches]] · [[Aging/Research colloquium|Research colloquium]].<br />
<br />
</div><br />
<div class="aj-section-title"><h2>Continue exploring</h2></div><div class="aj-tiles"><div class="aj-tile"><div class="aj-thumb">[[File:Bovine Pulmonary Artery Endothelial Cells Fluorescent Image.jpg|120px|frameless|link=Aging/Approaches to aging|alt=Fluorescence micrograph of bovine endothelial cells with labeled nuclei, actin and mitochondria.]]</div><div><div class="aj-tile-title">[[Aging/Approaches to aging|Approaches to aging]]</div><div class="aj-tile-desc">Evidence and functional outcomes</div></div></div><div class="aj-tile"><div class="aj-thumb aj-type-thumb">[[Aging/Evidence chain|→]]</div><div><div class="aj-tile-title">[[Aging/Evidence chain|Evidence chain]]</div><div class="aj-tile-desc">How studies generate new questions</div></div></div><div class="aj-tile"><div class="aj-thumb">[[File:DNA double helix.svg|120px|frameless|link=Aging/Research colloquium|alt=Schematic illustration of a DNA double helix.]]</div><div><div class="aj-tile-title">[[Aging/Research colloquium|Research colloquium]]</div><div class="aj-tile-desc">16 foundation assignments + 4 new deep dives</div></div></div></div><br />
<div class="aj-footer"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aj-context">[[Aging|Project overview]][[Aging/About the project|Goals & methods]][[Aging/Evidence chain|Evidence chain]]</div><div class="aj-meta">AI-assisted literature research and model building. No laboratory or clinical studies conducted by this project. No personal treatment plans.</div><div class="aj-credits">Image credits · Illustrations, not project data: [https://commons.wikimedia.org/wiki/File:Axolotl_Portrait.jpg Axolotl] — LoKiLeCh ([https://creativecommons.org/licenses/by-sa/3.0/ CC BY-SA 3.0]) · [https://commons.wikimedia.org/wiki/File:XBio_illustration_%E2%80%93_Neuron.png Neuron] — explorebiology (Explore Biology) ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0]) · [https://commons.wikimedia.org/wiki/File:DNA_double_helix.svg DNA] — Biochemlife ([https://creativecommons.org/licenses/by-sa/4.0/ CC BY-SA 4.0]) · [https://commons.wikimedia.org/wiki/File:Bovine_Pulmonary_Artery_Endothelial_Cells_Fluorescent_Image.jpg Bovine endothelial cells] — Erin Rod ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0])</div></div><br />
</div><br />
[[Category:Altern / Aging]]</div>Glanz